Erratum: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2- positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial (The Lancet (2010) 376 (687-697))

The Lancet

Volumn 376, Issue 9749, 2010, Pages 1302-

  Bang, Y J ^a   Van Cutsem, E ^a   Feyereislova, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 77958099652     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61918-6     Document Type: Erratum

References (5)

1. M May A Boulle S Phiri Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes Lancet 376 2010 449 457
2. P Braitstein A Boulle D Nash Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration J Womens Health 17 2008 47 55
3. AS Muula TJ Ngulube S Siziya Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review BMC Public Health 7 2007 63
4. A Greig D Peacock R Jewkes S Msimang Gender and AIDS: time to act AIDS 22 suppl 2 2008 S35 S43
5. Bakanda C, Birungi J, Mwesigwa R, et al. Rates of mortality by baseline CD4 cell count after initiating antiretroviral therapy among Ugandan HIV+ patients. Presented at the XVIII International AIDS Conference; Vienna, Austria; July 18–23, 2010.